PAPER Chen SK, Tvrdik P, Peden E, Cho S, Wu S, Spangrude G, Capecchi MR
SEARCH RESULTS
331254 RESULTS
Wai-Tong Chien on Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
COMMENT This is one of the very few large-sample cohort studies on aged-related stages of the pathological process in Alzheimer's disease among the European population. Of a total of 2,332 cases from one to 100 years old, 1,031 (44.2 percent) of them had β a
PAPER Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM
Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
Brain Res. 1989 Jan 16;477(1-2):90-9. PubMed: 2495152PAPER Ganier M, Lieberman P
Infantile agammaglobulinemia and immediate hypersensitivity to penicillin G.
JAMA. 1977 Apr 25;237(17):1852-3. PubMed: 576692PAPER Brooks MA, Hackman MR
Trace level determination of 1,4-benzodiazepines in blood by differential pulse polarography.
Anal Chem. 1975 Oct;47(12):2059-62. PubMed: 242233NEALS: Collaboration for a Cure to ALS
RESEARCH NEWS 2011-10-26 Research News Never mind raising a child. It takes a village to stage a high-power clinical trial for neurodegenerative disease. Or rather, make that a global network of dedicated doctors and scientists. In the field of amyotrophic lateral sclerosis (ALS)
Think Oligomers Are Bad? Think Again....
RESEARCH NEWS 2011-10-26 Research News When it comes to neurodegenerative diseases involving proteins that clump together, the consensus seems to be that small aggregates, or oligomers, are bad for cells, whereas larger ones, or amyloid fibrils, are less offensive. Although it’s
PAPER Orr HT
FTD and ALS: genetic ties that bind.
Neuron. 2011 Oct 20;72(2):189-90. PubMed: 22017980PAPER Khodr CE, Pedapati J, Han Y, Bohn MC
Inclusion of a portion of the native SNCA 3'UTR reduces toxicity of human S129A SNCA on striatal-projecting dopamine neurons in rat substantia nigra.
Dev Neurobiol. 2011 Oct 23; PubMed: 22021082PAPER Shi M, Furay AR, Sossi V, Aasly JO, Armaly J, Wang Y, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Zhang J
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
Neurobiol Aging. 2011 Oct 20; PubMed: 22019052PAPER Herges K, Millward JM, Hentschel N, Infante-Duarte C, Aktas O, Zipp F
Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
PLoS One. 2011;6(10):e25456. PubMed: 22022398PAPER Kells AP, Forsayeth J, Bankiewicz KS
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain.
Neurobiol Dis. 2011 Oct 14; PubMed: 22019719PAPER Kim J, Su SC, Wang H, Cheng AW, Cassady JP, Lodato MA, Lengner CJ, Chung CY, Dawlaty MM, Tsai LH, Jaenisch R
Functional integration of dopaminergic neurons directly converted from mouse fibroblasts.
Cell Stem Cell. 2011 Nov 4;9(5):413-9. PubMed: 22019014PAPER Djordjevic A, Djordjevic J, Elaković I, Adzic M, Matić G, Radojcic MB
Fluoxetine affects hippocampal plasticity, apoptosis and depressive-like behavior of chronically isolated rats.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):92-100. PubMed: 22019604PAPER Radak Z, Zhao Z, Goto S, Koltai E
Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA.
Mol Aspects Med. 2011 Aug;32(4-6):305-15. PubMed: 22020115Current Filters
No filters selected